Application and validation of a novel inflammatory score in the clinical grading of infectious endophthalmitis: The endophthalmitis management study - Report 2.
Endophthalmitis
endophthalmitis management study
grading scale
inflammatory score
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
entrez:
2
2
2023
pubmed:
3
2
2023
medline:
4
2
2023
Statut:
ppublish
Résumé
This study was conducted to describe and validate a novel inflammatory score (IS) system in the management of infectious endophthalmitis. This was a prospective comparative non-interventional observational study. The study included the patients with clinical signs and symptoms of acute post-cataract surgery endophthalmitis (surgery within 6 weeks) with visual acuity from 6/18 to light perception. IS was scored by the clinical picture at two-levels of four ocular tissues on a scale of 0 (normal) to 4 (severe). Four masked graders of different levels of experience evaluated slit-lamp photographs. The concordance correlation coefficient was assessed between the slit-lamp clinical grading and photographic grading. We measured the concordance correlation coefficient, Pearson's correlation (indicating precision), and the bias correction factor (indicating the accuracy). The study included 43 eyes of 43 patients. The concordance correlation coefficient was 0.99 (95% CI 0.995 to 0.998). Both Pearson's correlation coefficient and the bias correction were 0.99. The interclass correlation coefficient (ICC) was measured. The intra-rater ICC was 0.833 with good agreement (95% CI, 0.711 to 0.906; P < 0.001). Inter-rater ICC for consistency was 0.92 (95% CI 0.87 to 0.95). Inter-rater ICC for absolute agreement was 0.86 (95% CI 0.66 to 0.93). Currently used IS scoring in the study is a reliable, reproducible, and easy-to-apply scale to measure inflammation severity in endophthalmitis. We propose that it can have applications in decision-making for primary treatment and monitoring progression in acute infectious endophthalmitis.
Identifiants
pubmed: 36727325
pii: IndianJOphthalmol_2023_71_2_396_368924
doi: 10.4103/ijo.IJO_1274_22
pmc: PMC10228928
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
396-400Investigateurs
Vivek Pravin Dave
(VP)
Avantika Dogra
(A)
Taraprasad Das
(T)
Deepika C Parameshwarappa
(DC)
Hasnat Ali
(H)
Joveeta Joseph
(J)
Savitri Sharma
(S)
Anthony Vipin Das
(AV)
Raja Narayanan
(R)
Subhadra Jalali
(S)
Nayak Sameera
(N)
Umesh Behera
(U)
Avinash Pathengay
(A)
Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Ophthalmology. 1985 Apr;92(4):467-71
pubmed: 4000641
Sports Med. 2000 Jul;30(1):1-15
pubmed: 10907753
Arch Ophthalmol. 1990 Jun;108(6):857-60
pubmed: 2350288
Indian J Ophthalmol. 2021 Jul;69(7):1936-1941
pubmed: 34146061
Arch Ophthalmol. 1995 Dec;113(12):1479-96
pubmed: 7487614
J Clin Psychol. 1962 Jan;18:95-7
pubmed: 13873587
J Cataract Refract Surg. 2002 May;28(5):729-30
pubmed: 11978440
Am J Ophthalmol. 1959 May;47(5 Pt 2):171-6
pubmed: 13649856
Trans Am Ophthalmol Soc. 1992;90:505-59
pubmed: 1494833
Community Eye Health. 2014;27(85):4-5
pubmed: 24966453
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Antimicrob Agents Chemother. 2012 May;56(5):2485-92
pubmed: 22371888
Br J Ophthalmol. 1999 Sep;83(9):1050-5
pubmed: 10460774
Ophthalmology. 2012 Dec;119(12):2443-9
pubmed: 22858123
Indian J Ophthalmol. 1995 Sep;43(3):103-16
pubmed: 8822484
Indian J Ophthalmol. 2017 Dec;65(12):1396-1402
pubmed: 29208820